A pharmaceutical-related molecules dataset for reversed-phase chromatography retention time prediction built on combining pH and gradient time conditions.

High performance liquid chromatography Quantitative structure retention relationship Reverse phase liquid chromatography Small pharmaceutical compounds

Journal

Data in brief
ISSN: 2352-3409
Titre abrégé: Data Brief
Pays: Netherlands
ID NLM: 101654995

Informations de publication

Date de publication:
Jun 2022
Historique:
received: 05 01 2022
revised: 21 02 2022
accepted: 02 03 2022
entrez: 21 3 2022
pubmed: 22 3 2022
medline: 22 3 2022
Statut: epublish

Résumé

There is a rising interest in the modeling and predicting of chromatographic retention. The progress towards more complex and comprehensive models emphasized the need for broad reliable datasets. The present dataset comprises small pharmaceutical compounds selected to cover a wide range in terms of physicochemical properties that are known to impact the retention in reversed-phase liquid chromatography. Moreover, this dataset was analyzed at five pH with two gradient slopes. It provides a reliable dataset with a diversity of conditions and compounds to support the building of new models. To enhance the robustness of the dataset, the compounds were injected individually, and each sequence of injections included a quality control sample. This unambiguous detection of each compound as well as a systematic analysis of a quality control sample ensured the quality of the reported retention times. Moreover, three different liquid chromatographic systems were used to increase the robustness of the dataset.

Identifiants

pubmed: 35310817
doi: 10.1016/j.dib.2022.108017
pii: S2352-3409(22)00228-1
pmc: PMC8931345
doi:

Types de publication

Journal Article

Langues

eng

Pagination

108017

Informations de copyright

© 2022 The Author(s). Published by Elsevier Inc.

Déclaration de conflit d'intérêts

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

J Pharm Biomed Anal. 2016 Aug 5;127:176-83
pubmed: 26960942
J Chromatogr A. 2017 Feb 24;1486:50-58
pubmed: 27720174
Anal Chem. 2017 Feb 7;89(3):1870-1878
pubmed: 28208251

Auteurs

Thomas Van Laethem (T)

Laboratory for the Analysis of Medicines, University of Liège (ULiege), CIRM, B36 Tower 4 (route 688 CHU) +3, Avenue Hippocrate, 15, Liège 4000, Belgium.
Laboratory of Pharmaceutical Analytical Chemistry, University of Liège (ULiege), CIRM, B36 Tower 4 (route 688 CHU) +2, Avenue Hippocrate, 15, Liège 4000, Belgium.

Priyanka Kumari (P)

Laboratory for the Analysis of Medicines, University of Liège (ULiege), CIRM, B36 Tower 4 (route 688 CHU) +3, Avenue Hippocrate, 15, Liège 4000, Belgium.
Laboratory of Pharmaceutical Analytical Chemistry, University of Liège (ULiege), CIRM, B36 Tower 4 (route 688 CHU) +2, Avenue Hippocrate, 15, Liège 4000, Belgium.

Philippe Hubert (P)

Laboratory of Pharmaceutical Analytical Chemistry, University of Liège (ULiege), CIRM, B36 Tower 4 (route 688 CHU) +2, Avenue Hippocrate, 15, Liège 4000, Belgium.

Marianne Fillet (M)

Laboratory for the Analysis of Medicines, University of Liège (ULiege), CIRM, B36 Tower 4 (route 688 CHU) +3, Avenue Hippocrate, 15, Liège 4000, Belgium.

Pierre-Yves Sacré (PY)

Laboratory of Pharmaceutical Analytical Chemistry, University of Liège (ULiege), CIRM, B36 Tower 4 (route 688 CHU) +2, Avenue Hippocrate, 15, Liège 4000, Belgium.

Cédric Hubert (C)

Laboratory of Pharmaceutical Analytical Chemistry, University of Liège (ULiege), CIRM, B36 Tower 4 (route 688 CHU) +2, Avenue Hippocrate, 15, Liège 4000, Belgium.

Classifications MeSH